Vanguard Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$637M Sell
12,245,602
-585,901
-5% -$30.5M 0.01% 895
2025
Q1
$819M Sell
12,831,503
-450,211
-3% -$28.7M 0.01% 725
2024
Q4
$635M Buy
13,281,714
+386,618
+3% +$18.5M 0.01% 899
2024
Q3
$738M Buy
12,895,096
+13,637
+0.1% +$781K 0.01% 813
2024
Q2
$674M Sell
12,881,459
-167,794
-1% -$8.79M 0.01% 816
2024
Q1
$531M Sell
13,049,253
-210,261
-2% -$8.55M 0.01% 975
2023
Q4
$490M Buy
13,259,514
+152,870
+1% +$5.65M 0.01% 981
2023
Q3
$501M Sell
13,106,644
-29,621
-0.2% -$1.13M 0.01% 898
2023
Q2
$474M Sell
13,136,265
-383,374
-3% -$13.8M 0.01% 956
2023
Q1
$516M Buy
13,519,639
+215,792
+2% +$8.24M 0.01% 889
2022
Q4
$757M Sell
13,303,847
-31,308
-0.2% -$1.78M 0.02% 679
2022
Q3
$527M Buy
13,335,155
+38,342
+0.3% +$1.52M 0.02% 806
2022
Q2
$585M Buy
13,296,813
+46,893
+0.4% +$2.06M 0.02% 766
2022
Q1
$528M Sell
13,249,920
-245,993
-2% -$9.81M 0.01% 924
2021
Q4
$543M Sell
13,495,913
-129,828
-1% -$5.22M 0.01% 946
2021
Q3
$554M Sell
13,625,741
-12,563
-0.1% -$511K 0.01% 920
2021
Q2
$619M Buy
13,638,304
+380,438
+3% +$17.3M 0.02% 855
2021
Q1
$553M Buy
13,257,866
+108,163
+0.8% +$4.51M 0.02% 896
2020
Q4
$562M Buy
13,149,703
+422,287
+3% +$18M 0.02% 823
2020
Q3
$334M Sell
12,727,416
-320,183
-2% -$8.41M 0.01% 962
2020
Q2
$350M Sell
13,047,599
-850,615
-6% -$22.8M 0.01% 933
2020
Q1
$250M Sell
13,898,214
-104,941
-0.7% -$1.89M 0.01% 999
2019
Q4
$248M Sell
14,003,155
-224,974
-2% -$3.99M 0.01% 1259
2019
Q3
$221M Buy
14,228,129
+931,189
+7% +$14.4M 0.01% 1276
2019
Q2
$228M Sell
13,296,940
-221,250
-2% -$3.8M 0.01% 1277
2019
Q1
$218M Buy
13,518,190
+46,272
+0.3% +$745K 0.01% 1281
2018
Q4
$197M Buy
13,471,918
+154,554
+1% +$2.26M 0.01% 1251
2018
Q3
$242M Buy
13,317,364
+622,518
+5% +$11.3M 0.01% 1252
2018
Q2
$214M Buy
12,694,846
+674,483
+6% +$11.4M 0.01% 1300
2018
Q1
$235M Buy
12,020,363
+823,768
+7% +$16.1M 0.01% 1180
2017
Q4
$227M Buy
11,196,595
+1,205,190
+12% +$24.4M 0.01% 1223
2017
Q3
$174M Buy
9,991,405
+396,193
+4% +$6.88M 0.01% 1373
2017
Q2
$123M Buy
9,595,212
+831,654
+9% +$10.7M 0.01% 1552
2017
Q1
$114M Buy
8,763,558
+311,215
+4% +$4.03M 0.01% 1587
2016
Q4
$83.5M Buy
8,452,343
+253,084
+3% +$2.5M ﹤0.01% 1733
2016
Q3
$99M Buy
8,199,259
+591,031
+8% +$7.14M 0.01% 1561
2016
Q2
$65.7M Buy
7,608,228
+71,340
+0.9% +$616K ﹤0.01% 1776
2016
Q1
$71.4M Buy
7,536,888
+96,683
+1% +$916K ﹤0.01% 1689
2015
Q4
$129M Buy
7,440,205
+277,302
+4% +$4.81M 0.01% 1281
2015
Q3
$96.2M Buy
7,162,903
+300,142
+4% +$4.03M 0.01% 1458
2015
Q2
$155M Buy
6,862,761
+266,705
+4% +$6.02M 0.01% 1235
2015
Q1
$94.2M Buy
6,596,056
+311,418
+5% +$4.45M 0.01% 1548
2014
Q4
$60.6M Buy
6,284,638
+23,836
+0.4% +$230K ﹤0.01% 1729
2014
Q3
$57M Buy
6,260,802
+105,276
+2% +$958K ﹤0.01% 1726
2014
Q2
$60.8M Buy
6,155,526
+3,439
+0.1% +$34K ﹤0.01% 1730
2014
Q1
$78.1M Buy
6,152,087
+877,061
+17% +$11.1M 0.01% 1518
2013
Q4
$79.1M Buy
5,275,026
+167,368
+3% +$2.51M 0.01% 1473
2013
Q3
$56.4M Buy
5,107,658
+177,176
+4% +$1.96M 0.01% 1646
2013
Q2
$39.1M Buy
+4,930,482
New +$39.1M ﹤0.01% 1784